中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2012年
1期
7-11
,共5页
蒋伟平%吴君心%陈传本%陈荔莎%潘建基
蔣偉平%吳君心%陳傳本%陳荔莎%潘建基
장위평%오군심%진전본%진려사%반건기
鼻咽肿瘤,老年/放射疗法%放射疗法,常规%预后
鼻嚥腫瘤,老年/放射療法%放射療法,常規%預後
비인종류,노년/방사요법%방사요법,상규%예후
Nasopharyngeal neoplasms,elderly/radiotherapy%Radiotherapy,conventional%Prognosis
目的 评价单纯放疗老年鼻咽癌患者的远期疗效及不良反应.方法 回顾分析本院1995-1998年间经病理证实的初治无远处转移、年龄≥65岁的老年鼻咽癌患者95例的临床资料,分析其远期生存率及不良反应.采用Kaplan-Meier法计算局部控制率和无远处转移生存率,Logrank法单因素预后分析,Cox模型多因素预后分析.结果 随访率为98%.3、5、8年局部控制率和无远处转移生存率分别为89%、87%、84%和85%、79%、79%.急性不良反应主要为1、2级血液学反应(34例)、皮肤反应(61例)和口腔黏膜炎(63例);晚期不良反应主要为听力下降(8%)、张口困难(10%)和颅神经损伤(5%).单因素分析结果显示影响局部控制率因素有放疗是否中断(χ2=7.45,P=0.006)、颈部淋巴结疗效(χ2 =4.17,P=0.041),影响无远处转移生存率有T分期(χ2=4.16,p=0.032)、N分期(χ2 =4.66,P=0.031)、放疗是否中断(χ2=9.42,P=0.002);多因素分析结果显示影响局部控制率因素有放疗是否中断(χ2 =6.19,P=0.013)和颈部淋巴结疗效(χ2=12.26,P=0.002),影响无远处转移生存率因素有N分期(χ2 =15.06,P=0.000)和放疗是否中断(χ2=21.62,P=0.000).结论 老年鼻咽癌患者行单纯常规放疗即可取得较好疗效且不良反应较轻;N分期早、放疗顺利完成和颈部淋巴结完全缓解的远期预后良好.
目的 評價單純放療老年鼻嚥癌患者的遠期療效及不良反應.方法 迴顧分析本院1995-1998年間經病理證實的初治無遠處轉移、年齡≥65歲的老年鼻嚥癌患者95例的臨床資料,分析其遠期生存率及不良反應.採用Kaplan-Meier法計算跼部控製率和無遠處轉移生存率,Logrank法單因素預後分析,Cox模型多因素預後分析.結果 隨訪率為98%.3、5、8年跼部控製率和無遠處轉移生存率分彆為89%、87%、84%和85%、79%、79%.急性不良反應主要為1、2級血液學反應(34例)、皮膚反應(61例)和口腔黏膜炎(63例);晚期不良反應主要為聽力下降(8%)、張口睏難(10%)和顱神經損傷(5%).單因素分析結果顯示影響跼部控製率因素有放療是否中斷(χ2=7.45,P=0.006)、頸部淋巴結療效(χ2 =4.17,P=0.041),影響無遠處轉移生存率有T分期(χ2=4.16,p=0.032)、N分期(χ2 =4.66,P=0.031)、放療是否中斷(χ2=9.42,P=0.002);多因素分析結果顯示影響跼部控製率因素有放療是否中斷(χ2 =6.19,P=0.013)和頸部淋巴結療效(χ2=12.26,P=0.002),影響無遠處轉移生存率因素有N分期(χ2 =15.06,P=0.000)和放療是否中斷(χ2=21.62,P=0.000).結論 老年鼻嚥癌患者行單純常規放療即可取得較好療效且不良反應較輕;N分期早、放療順利完成和頸部淋巴結完全緩解的遠期預後良好.
목적 평개단순방료노년비인암환자적원기료효급불량반응.방법 회고분석본원1995-1998년간경병리증실적초치무원처전이、년령≥65세적노년비인암환자95례적림상자료,분석기원기생존솔급불량반응.채용Kaplan-Meier법계산국부공제솔화무원처전이생존솔,Logrank법단인소예후분석,Cox모형다인소예후분석.결과 수방솔위98%.3、5、8년국부공제솔화무원처전이생존솔분별위89%、87%、84%화85%、79%、79%.급성불량반응주요위1、2급혈액학반응(34례)、피부반응(61례)화구강점막염(63례);만기불량반응주요위은력하강(8%)、장구곤난(10%)화로신경손상(5%).단인소분석결과현시영향국부공제솔인소유방료시부중단(χ2=7.45,P=0.006)、경부림파결료효(χ2 =4.17,P=0.041),영향무원처전이생존솔유T분기(χ2=4.16,p=0.032)、N분기(χ2 =4.66,P=0.031)、방료시부중단(χ2=9.42,P=0.002);다인소분석결과현시영향국부공제솔인소유방료시부중단(χ2 =6.19,P=0.013)화경부림파결료효(χ2=12.26,P=0.002),영향무원처전이생존솔인소유N분기(χ2 =15.06,P=0.000)화방료시부중단(χ2=21.62,P=0.000).결론 노년비인암환자행단순상규방료즉가취득교호료효차불량반응교경;N분기조、방료순리완성화경부림파결완전완해적원기예후량호.
Objective To evaluate the outcomes and toxicities of elderly nasopharyngeal carcinoma (NPC) treated with conventional radiotherapy alone.Methods From January 1995 to December 1998,95 newly diagnosed nasopharyngeai carcinoma with age ≥65 years treated in our hospital.The clinical data were analyzed retrospectively.Kaplan-Meier method was used for analysis of local-regional control survival and distant metastasis-free survival. The Logrank test was used for univariate prognostic analysis and Cox regression was used for multivariable prognostic analysis.Results The follow-up rate was 98%.The 3-,5- and 8-year local-regional control (LRC) and distant metastasis-free survival (DMFS) rates were 89%,87%,84% and 85%,79%,79%,respectively. The most common acute toxicities were grade1-2 leukopenia (36%),skin reaction (64%) and mucositis (66%).The most frequent late toxicities were hearing impairment (8%),trismus ( 10% ) and radiation-induced cranial neuropathy (5%).In univariate analysis,interruption of radiotherapy ( χ2 =7.45,P =0.006 ) and regional neck lymph nodes response (χ2 =4.17,P=0.041 ) was the prognostic factors for LRC,T stage (χ2 =4.16,P=0.032),N stage ( χ2 =4.66,P =0.031 ) and interruption of radiotherapy ( χ2 =9.42,P =0.002 ) was the prognostic factors for DMFS. In multivariable analysis,interruption of radiotherapy and the regional neck lymph nodes response were the prognostic factors for LRC (χ2=6.19,P=0.013 and χ2=12.16,P=0.002;respectively),N stage and radiotherapy interruption were prognostic factors for DMFS.(χ2=15.06,P =0.000 and χ2 =21.62,P =0.000 ; respectively ).Conclusions Conventional radiotherapy alone for elder NPC can produce satisfactory results with acceptable treatment-relative toxicities.Our experience showed that the early N stage,without radiotherapy interruption and good regional lymph nodes response had a good longterm prognosis.